ESMO 2025 News: Can Adjuvant Pembrolizumab Stave Off MCC Spread?
Adjuvant immunotherapy after surgery may help prevent the metastasis of Merkel cell carcinoma (MCC), but it did not significantly reduce the overall risk of recurrence, according to a new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).